Please login to the form below

Not currently logged in
Email:
Password:

medicines optimisation

This page shows the latest medicines optimisation news and features for those working in and with pharma, biotech and healthcare.

UK pharma to work with innovation network on NHS uptake

UK pharma to work with innovation network on NHS uptake

The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of  medicines and other 'biomedical innovations' ... These areas include economic growth, digital

Latest news

More from news
Approximately 10 fully matching, plus 16 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • ABPI names NHS partnership manager ABPI names NHS partnership manager

    In his new role, he will manage the four ABPI regional partnership managers and lead ABPI activities in academic health science networks and medicines optimisation. ... ensure appropriate medicines and technologies are available to all eligible

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • NHS medicines optimisation milestone

    Regional Medicines Optimisation Committees(RMOCs), which were launched last year, have been playing a pivotal role in working with NHS commissioners and providers on best value biologics and helping them to ... by 2020/21 if the NHS embraces the use of

  • Sir Bruce Keogh is appointed chair of judges for HSJ Awards

    The eight new awards include acute or specialist services redesign, patient digital participation, creating a supportive staff culture and optimisation of medicines management.

  • Unique forum will unite NHS and industry to drive innovation

    The event aims to help industry develop stronger relationships with leaders from NHS England, Regional Medicines Optimisation Committees (RMOCs), Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs), and influence

  • How will the NHS’s new medicines savings drive affect pharma?

    The CCGs will be monitored by four Regional Medicines Optimisation Committees(RMOCs) which were launched recently to avoid duplication when evaluating medicines, particularly those which are not evaluated by NICE. . ... Thanks to powerful data analytics

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics